
The corona virus disease (COVID-19) has resulted in an immense health burden that has become the third leading cause of death and potentially contributed to a decline in life expectancy. A potential consequence of COVID-19 is reduced ACE2 activity that may exacerbate the acute inflammatory events and contribute to the effects of long COVID-19. Greater disease severity is also evident in male COVID-19 patients, which may reflect underlying sex differences in regulating the two distinct functional arms of the RAS. The current review critically evaluates the evidence for an activated RAS in COVID-19 subjects and whether this system contributes to the greater severity of severe acute respiratory syndrome-related coronavirus-2 infection in males compared to females.
Like
Save
Share